NEWS

Birgi Mefar and Sanofi Turkey have partnered for a new technology transfer and local production project.

Birgi Mefar and Sanofi Turkey have partnered for a new technology transfer and local production project. Within the scope of the cooperation, Sanofi's antibiotic product, which reached a turnover of TL 22 million in the Turkish market, will be brought into domestic production with two years of work and will be exported to nearly 40 countries. This investment, worth three million euros, will add more than 500 million TL to Turkey in the period 2020-2026.

Birgi Mefar Group Board Announcement

BirgiMefar Group announces that Mr. Mehmet Faik Somer has been appointed as the Group CEO effective as of 5th March, 2019.

Our Group's Interview with PharmaBoard

Our Group's Interview with PharmaBoard We would like to inform our customers that we have had an interview with PharmaBoard about the insights into our Group. The full script of the interview can be read from the link below

Birgi Mefar Group participated CPHI / ICSE Worldwide 2018 held in Madrid

Birgi Mefar Group participated CPHI / ICSE Worldwide 2018 held in Madrid We are proud to announce that our Birgi Mefar Team has attended the CPHI / ICSE Worldwide fair in Madrid between the dates of October 9-11 with its 68m2 booth located in Hall 3 designated for contract manufacturers (CMOs

Mefar is now the first company in pharmaceutical industry that is certificated with ISO 45001 Occupational Health and Safety Management System.

Mefar is now the first company in pharmaceutical industry that is certificated with ISO 45001 Occupational Health and Safety Management System. 15.08.2018

next